Dtsch Med Wochenschr 2006; 131(16): 884-887
DOI: 10.1055/s-2006-939863
Prinzip & Perspektive | Review article
Regenerative Medizin, Kardiologie
© Georg Thieme Verlag KG Stuttgart · New York

Atriales Remodeling und Anti-Remodeling-Therapie bei Vorhofflimmern

Atrial remodeling and anti-remodeling therapy in atrial fibrillationT. Neumann1 , H. Hölschermann2
  • 1Medizinische Klinik I, Kardiologie und Angiologie, Universitätsklinikum Gießen und Marburg
  • 2Medizinische Klinik I, Kardiologie und Angiologie, Hochtaunus-Kliniken Bad Homburg
Further Information

Publication History

eingereicht: 19.12.2005

akzeptiert: 16.3.2006

Publication Date:
20 April 2006 (online)

Literatur

  • 1 Ausma J, Wijfells M, Thone F. et al . Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat.  Circulation. 1997;  96 3157-3163
  • 2 Corley S D, Epstein A E, DiMarco J P. et al . Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-UP Investigation of Rhythm Management (AFFIRM) study.  Circulation. 2004;  109 1509-1513
  • 3 Ehrlich J R, Cha T J, Zhang L. et al . Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium.  J Physiol. 2004;  557 583-597
  • 4 Frustaci A, Chimenti C, Bellocci F. et al . Histological substrate of atrial biopsies in patients with lone atrial fibrillation.  Circulation. 1997;  96 1180-1184
  • 5 Fuster V, Rydèn L E, Asinger R W. et al . Guidelines for the management of patients with atrial fibrillation: executive summary.  Circulation. 2001;  104 2118-2150
  • 6 Goette A, Arndt M, Rocken C. et al . Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans.  Circulation. 2000;  101 2678-2681
  • 7 Goldstein R N, Stambler B S. New antiarrhythmic drugs for prevention of atrial fibrillation.  Progress in Cardiovascular diseases. 2005;  48 193-208
  • 8 Hanna N, Cardin S, Leung T K. et al . Differences in atrial versus ventricular remodelling in dogs with ventricular tachypacing-induced congestive heart failure.  Cardiovasc Res. 2004;  63 236-244
  • 9 Lopez B, Querejeta R, Varo N. et al . Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients.  Circulation. 2001;  104 286-291
  • 10 Madrid A H, Peng J, Zamora J. et al . The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials.  PACE. 2004;  27 1405-1410
  • 11 Milliez P, DeAngelis N, Rucker-Martin C. et al . Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction.  European Heart Journal. 2005;  26 2193-2199
  • 12 Morillo C A, Klein G J, Jones D L. et al . Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation.  Circulation. 1995;  91 1588-1595
  • 13 Nakamura Y, Nakamura K, Fukushima-Kusano K. et al . Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis.  Thromb Res. 2003;  111 137-142
  • 14 Nattel S. New ideas about atrial fibrillation 50 years on.  Nature. 2002;  415 219-226
  • 15 Reant P, Lafitte S, Jais P. et al . Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation.  Circulation. 2005;  112 2896-2903
  • 16 Schotten U, Duytschaever M, Ausma J. et al . Electrical and contractile remodeling during the first days of atrial fibrillation go hand in hand.  Circulation. 2003;  107 1433-1439
  • 17 Shinagawa K, Shiroshita-Takeshita A, Schram G, Nattel S. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium.  Circulation. 2003;  107 1440-1446
  • 18 Tsao H M, Wu M H, Huang B H. et al . Morphologic remodeling of the pulmonary veins and left atrium after catheter ablation of atrial fibrillation: insights from long-term follow-up of three-dimensional magnetic resonance imaging.  J Cardiovasc Electrophysiol. 2005;  16 7-12
  • 19 Wetzel U, Boldt A, Lauschke J. et al . Expression of connexins 40 and 43 in human left atrium in atrial fibrillation in different aetiologies.  Heart. 2005;  91 166-170
  • 20 Yue L, Feng J, Gaspo R. et al . Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation.  Circ Res. 1997;  81 512-525

Priv.-Doz. Dr. Hans Hölschermann

Medizinische Klinik I - Kardiologie und Angiologie, Hochtaunus-Kliniken Bad Homburg

Urseler Str. 33

61348 Bad Homburg

Phone: 06172-143132

Fax: 06172-144915

Email: hans.hoelschermann@hochtaunus-kliniken.de

    >